Increasing Concerns Over Radiation Exposure Driving Radiation Dose Management Market

The global radiation dose management (RDM) market value stood at $129.8 million in 2016 and it is predicted to rise to $1.7 billion by 2023. Furthermore, the market will demonstrate a CAGR of 46% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major factors fueling the expansion of the market are the surging concerns being raised over radiation exposure, rising focus of healthcare facilities on providing improved patient care, and soaring public awareness about the harmful effects of exposure to radiation.

Exposure to radiation can cause various life-threatening diseases, such as cancer and radiation sickness. Nausea, vomiting, diarrhea, confusion, fainting, mouth and skin sores, bleeding, and hair loss are the most common symptoms of radiation sickness. As patient care is the primary focus of radiation dose management, some novel web-based management systems that utilize the Microsoft cloud technology to report, analyze, and track practice-level radiation dose data are being launched across the world. For example, GE Healthcare has developed a data management solution called DoseWatch Explore, which is basically a cloud-based RDM software suite, that analyses, reports, and tracks practice-level radiation dose data for GE computed tomography (CT) systems.

With the help of GE’s InSite connection and Microsoft Azure cloud technology, DoseWatch Explore gathers radiation data directly from the CT scanner, without requiring any additional hardware infrastructure, installation, or integration. The use of these solutions for managing radiation dose assists in mitigating the adverse effects of radiation on humans. Depending on product & services, the radiation dose management market is divided into services and solutions. These solutions and services are extensively used for monitoring and tracking the radiation dose in CT.

The market is also categorized, based on modality, into CT, nuclear medicine, fluoroscopy and interventional imaging, and radiography and mammography. Out of these, the CT category dominated the market in 2016. This was because this modality comprises very high doses of radiation and thus, its high exposure causes various illnesses and issues in patients. When end user is taken into consideration, the market is classified into hospitals and super specialty clinics.

Globally, North America held the largest share in the RDM market in the years gone by, with the U.S. generating higher revenue in the market in comparison to Canada. This was because of the high incidence of chronic diseases, large-scale use of radiation dose management software, and high requirement for CT examinations in the region. Moreover, in the U.S., the Medical Imaging and Technology Alliance (MITA) has taken various measures for optimizing the patient dose all over the industry, thereby supporting the advancement of the market in the region.

Comments are closed